Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

about

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

Item

http://www.wikidata.org/entity/Q50285710

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

@en

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

@nl

type

Item

label

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

@en

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

@nl

prefLabel

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

@en

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

@nl

P1476

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study.

@en

P2093

Anne Freimoser-Grundschober

http://www.w3.org/2001/XMLSchema#string

Christian Klein

http://www.w3.org/2001/XMLSchema#string

Rolf Zijlma

http://www.w3.org/2001/XMLSchema#string

Rudi A J O Dierckx

http://www.w3.org/2001/XMLSchema#string

Siddesh V Hartimath

http://www.w3.org/2001/XMLSchema#string

Tapan K Nayak

http://www.w3.org/2001/XMLSchema#string

Valeria Manuelli

http://www.w3.org/2001/XMLSchema#string

P2860

The IL-2 receptor complex: its structure, function, and target genes

Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma.

Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells

The biology of interleukin-2.

IL-2- and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets.

Selective in vitro growth of T lymphocytes from normal human bone marrows.

Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets

Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells.

P304

7162-7174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23852

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Signore

E F J de Vries

P577

2018-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29467958

http://www.w3.org/2001/XMLSchema#string

P932

5805544

http://www.w3.org/2001/XMLSchema#string